OPKO Health, Inc.
$1.53B- Market cap
- $1.21B
- Debt
- +$687.93M
- Cash
- −$364.41M
Capital structure 64% equity / 36% debt · EV / Revenue 2.53x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: OPK stock price at discount vs WFC $1.62 current versus $2.53 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WFC's multiple
Implied fair value · at OPK's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: OPK FY 2025 (ended Dec 31, 2025) · WFC FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 64% equity / 36% debt · EV / Revenue 2.53x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 59% equity / 41% debt
WFC carries the larger enterprise value at $465.16B against $1.53B; OPK trades on the lower EV / Revenue multiple (2.53x vs 5.33x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OPKO Health, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
WELLS FARGO & COMPANY/MN · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.54x
1.07x
Net debt / EBITDA
Leverage against operating earnings
-3.03x
—
Cash and equivalents
Liquid reserves on the balance sheet
$364.41M
—
Total debt
Interest-bearing obligations outstanding
$687.93M
$193.04B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMARIN CORP PLC\UK
OPK vs AMRN
Sarepta Therapeutics, Inc.
OPK vs SRPT
Amphastar Pharmaceuticals, Inc.
OPK vs AMPH
SUPERNUS PHARMACEUTICALS, INC.
OPK vs SUPN
Harmony Biosciences Holdings, Inc.
OPK vs HRMY
JPMorgan Chase & Co.
OPK vs JPM
Bank of America Corporation
OPK vs BAC
Citigroup Inc.
OPK vs C
The Goldman Sachs Group, Inc.
OPK vs GS
Morgan Stanley
OPK vs MS
Capital One Financial Corporation
OPK vs COF
TRUIST FINANCIAL CORP
OPK vs TFC
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.